Pulmonary Hypertension Trial, Recruiting NCT06775028 Sponsor: Heart Care Foundation Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06775028
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an outpatient (not currently admitted to hospital), of any sex, and are 65 years old or older
  • You have been diagnosed with atrial fibrillation (an irregular heartbeat) — whether newly diagnosed or long-standing — confirmed by a heart tracing test (ECG) or a monitor worn over a period of time
  • You have at least one other long-term health condition alongside your atrial fibrillation, such as: high blood pressure (treated with at least 2 blood pressure medications), coronary artery disease, peripheral artery disease, heart failure, stroke or mini-stroke (TIA), diabetes, chronic lung disease (COPD), or chronic kidney disease (CKD)

Who may not be able to join:

  • You have an artificial (mechanical) heart valve or a significant narrowing of the mitral valve in your heart
  • You are not willing to take part or sign a consent form agreeing to join the study
  • You are unable to understand what the study involves or cannot attend follow-up appointments
  • You have a serious illness where life expectancy is expected to be less than 12 months
  • You are already taking part in another clinical intervention study
  • You do not have a compatible device for use with the study's digital tool called iABC (this applies only to certain trial locations) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390555101211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Heart Care Foundation
Registry
ClinicalTrials.gov
Start date
11 April 2024
Est. completion
31 January 2026

Where this trial is recruiting

🇧🇬 Bulgaria 🇩🇰 Denmark 🇮🇹 Italy 🇷🇴 Romania 🇷🇸 Serbia 🇪🇸 Spain

Primary endpoints

Impact of iABC on all cause unplanned hospitalization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov